Dana Investment Advisors Inc. Has $3.59 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Dana Investment Advisors Inc. lowered its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 26.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,527 shares of the company’s stock after selling 14,106 shares during the period. Dana Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $3,593,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in CL. D Orazio & Associates Inc. boosted its position in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the last quarter. Commonwealth Financial Services LLC lifted its stake in shares of Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after purchasing an additional 118 shares during the period. Lantz Financial LLC boosted its position in shares of Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Horizon Kinetics Asset Management LLC grew its stake in Colgate-Palmolive by 4.2% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock worth $322,000 after purchasing an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc increased its holdings in Colgate-Palmolive by 1.0% in the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company’s stock worth $1,182,000 after purchasing an additional 130 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CL shares. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $101.61.

View Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 1.7 %

NYSE CL opened at $93.30 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The business has a fifty day simple moving average of $88.74 and a 200 day simple moving average of $95.26. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The firm has a market capitalization of $75.72 billion, a P/E ratio of 26.51, a PEG ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.